EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.56 | (2-[4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl]ethoxy)acetic acid | - |
Homo sapiens | |
2.1.1.56 | (2R,6S)-2,6-dimethyl-4-[2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 1,8-dihydroxyanthracen-9(10H)-one | - |
Homo sapiens | |
2.1.1.56 | 1,8-dihydroxyanthracen-9(10H)-one | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 1-(4-tert-butylphenyl)-N-methyl-N-[(naphthalen-1-yl)methyl]methanamine | - |
Homo sapiens | |
2.1.1.56 | 1-(4-tert-butylphenyl)-N-methyl-N-[(naphthalen-1-yl)methyl]methanamine | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 1-(diphenylmethyl)-4-methylpiperazine hydrochloride (1:1) | - |
Homo sapiens | |
2.1.1.56 | 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine | - |
Homo sapiens | |
2.1.1.56 | 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 1-[(4-chlorophenyl)(phenyl)methyl]-4-methylpiperazine | - |
Homo sapiens | |
2.1.1.56 | 1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine | - |
Homo sapiens | |
2.1.1.56 | 1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine | - |
Homo sapiens | |
2.1.1.56 | 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 1-[bis(4-fluorophenyl)methyl]-4-[(2Z)-3-phenylprop-2-en-1-yl]piperazine | - |
Homo sapiens | |
2.1.1.56 | 1-[bis(4-fluorophenyl)methyl]-4-[(2Z)-3-phenylprop-2-en-1-yl]piperazine | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 2,3,7,8-tetrahydroxy[1]benzopyrano[5,4,3-cde][1]benzopyran-5,10-dione | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 2-(2-[4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl]ethoxy)ethan-1-ol | - |
Homo sapiens | |
2.1.1.56 | 3,3',4',5,5',7-hexahaxdroxyflavone | - |
Homo sapiens | |
2.1.1.56 | 3,3',4',5,5',7-hexahaxdroxyflavone | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 3,3',4',5,7-pentahydroxyflavone | - |
Homo sapiens | |
2.1.1.56 | 3,3',4',5,7-pentahydroxyflavone | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 3,4',5,7-tetrahydroxyflavone | - |
Homo sapiens | |
2.1.1.56 | 3,4',5,7-tetrahydroxyflavone | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | 3,8-diamino-5-[3-[diethyl(methyl)azaniumyl]propyl]-6-phenylphenanthridin-5-ium | - |
Homo sapiens | |
2.1.1.56 | 3,8-diamino-5-[3-[diethyl(methyl)azaniumyl]propyl]-6-phenylphenanthridin-5-ium | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | bis[6-(dimethylamino)-2-[(E)-2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methylquinolin-1-ium] 4-[(3-carboxy-2-oxidonaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylate | - |
Homo sapiens | |
2.1.1.56 | bis[6-(dimethylamino)-2-[(E)-2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methylquinolin-1-ium] 4-[(3-carboxy-2-oxidonaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylate | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | N-(2-[[(4-methoxyphenyl)methyl](pyrimidin-2-yl)amino]ethyl)-N,N-dimethylhexadecan-1-aminium | - |
Homo sapiens | |
2.1.1.56 | N-(2-[[(4-methoxyphenyl)methyl](pyrimidin-2-yl)amino]ethyl)-N,N-dimethylhexadecan-1-aminium | - |
Severe acute respiratory syndrome-related coronavirus | |
2.1.1.56 | sinefungin | 98.2% inhibition at 0.05 mM | Homo sapiens | |
2.1.1.56 | sinefungin | 98.2% inhibition at 0.05 mM | Severe acute respiratory syndrome-related coronavirus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.56 | S-adenosyl-L-methionine + a 5'-(5'-triphosphoguanosine)-[mRNA] | Homo sapiens | - |
S-adenosyl-L-homocysteine + a 5'-(N7-methyl 5'-triphosphoguanosine)-[mRNA] | - |
? | |
2.1.1.56 | S-adenosyl-L-methionine + a 5'-(5'-triphosphoguanosine)-[mRNA] | Severe acute respiratory syndrome-related coronavirus | - |
S-adenosyl-L-homocysteine + a 5'-(N7-methyl 5'-triphosphoguanosine)-[mRNA] | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.56 | Homo sapiens | - |
- |
- |
2.1.1.56 | Severe acute respiratory syndrome-related coronavirus | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.56 | additional information | no activity with 7mGpppA | Homo sapiens | ? | - |
- |
|
2.1.1.56 | additional information | no activity with 7mGpppA | Severe acute respiratory syndrome-related coronavirus | ? | - |
- |
|
2.1.1.56 | S-adenosyl-L-methionine + a 5'-(5'-triphosphoguanosine)-[mRNA] | - |
Homo sapiens | S-adenosyl-L-homocysteine + a 5'-(N7-methyl 5'-triphosphoguanosine)-[mRNA] | - |
? | |
2.1.1.56 | S-adenosyl-L-methionine + a 5'-(5'-triphosphoguanosine)-[mRNA] | - |
Severe acute respiratory syndrome-related coronavirus | S-adenosyl-L-homocysteine + a 5'-(N7-methyl 5'-triphosphoguanosine)-[mRNA] | - |
? | |
2.1.1.56 | S-adenosyl-L-methionine + GpppAC4 | - |
Homo sapiens | S-adenosyl-L-homocysteine + 7mGpppAC4 | - |
? | |
2.1.1.56 | S-adenosyl-L-methionine + GpppAC4 | - |
Severe acute respiratory syndrome-related coronavirus | S-adenosyl-L-homocysteine + 7mGpppAC4 | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.1.1.56 | ? | x * 60000, SDS-PAGE | Homo sapiens |
2.1.1.56 | ? | x * 60000, SDS-PAGE | Severe acute respiratory syndrome-related coronavirus |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.56 | cap N7-MTase | - |
Homo sapiens |
2.1.1.56 | cap N7-MTase | - |
Severe acute respiratory syndrome-related coronavirus |
2.1.1.56 | cap-methyltransferase | - |
Homo sapiens |
2.1.1.56 | cap-methyltransferase | - |
Severe acute respiratory syndrome-related coronavirus |
2.1.1.56 | nsp14 | - |
Severe acute respiratory syndrome-related coronavirus |
2.1.1.56 | RNA N7-MTase | - |
Homo sapiens |
2.1.1.56 | RNA N7-MTase | - |
Severe acute respiratory syndrome-related coronavirus |
2.1.1.56 | RNMT | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.1.1.56 | 0.000019 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 2,3,7,8-tetrahydroxy[1]benzopyrano[5,4,3-cde][1]benzopyran-5,10-dione | |
2.1.1.56 | 0.00005 | - |
at pH 8.0 and 30°C | Homo sapiens | 1,8-dihydroxyanthracen-9(10H)-one | |
2.1.1.56 | 0.000112 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | sinefungin | |
2.1.1.56 | 0.00032 | - |
at pH 8.0 and 30°C | Homo sapiens | 3,3',4',5,5',7-hexahaxdroxyflavone | |
2.1.1.56 | 0.0004 | - |
at pH 8.0 and 30°C | Homo sapiens | 3,3',4',5,7-pentahydroxyflavone | |
2.1.1.56 | 0.00074 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 3,3',4',5,5',7-hexahaxdroxyflavone | |
2.1.1.56 | 0.001 | - |
at pH 8.0 and 30°C | Homo sapiens | N-(2-[[(4-methoxyphenyl)methyl](pyrimidin-2-yl)amino]ethyl)-N,N-dimethylhexadecan-1-aminium | |
2.1.1.56 | 0.00128 | - |
at pH 8.0 and 30°C | Homo sapiens | 1-(4-tert-butylphenyl)-N-methyl-N-[(naphthalen-1-yl)methyl]methanamine | |
2.1.1.56 | 0.0013 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 3,3',4',5,7-pentahydroxyflavone | |
2.1.1.56 | 0.0015 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | N-(2-[[(4-methoxyphenyl)methyl](pyrimidin-2-yl)amino]ethyl)-N,N-dimethylhexadecan-1-aminium | |
2.1.1.56 | 0.002 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 1,8-dihydroxyanthracen-9(10H)-one | |
2.1.1.56 | 0.0045 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | bis[6-(dimethylamino)-2-[(E)-2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methylquinolin-1-ium] 4-[(3-carboxy-2-oxidonaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylate | |
2.1.1.56 | 0.0051 | - |
at pH 8.0 and 30°C | Homo sapiens | bis[6-(dimethylamino)-2-[(E)-2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methylquinolin-1-ium] 4-[(3-carboxy-2-oxidonaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylate | |
2.1.1.56 | 0.0055 | - |
at pH 8.0 and 30°C | Homo sapiens | 3,8-diamino-5-[3-[diethyl(methyl)azaniumyl]propyl]-6-phenylphenanthridin-5-ium | |
2.1.1.56 | 0.0062 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine | |
2.1.1.56 | 0.0073 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 1-[bis(4-fluorophenyl)methyl]-4-[(2Z)-3-phenylprop-2-en-1-yl]piperazine | |
2.1.1.56 | 0.0088 | - |
at pH 8.0 and 30°C | Homo sapiens | 1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine | |
2.1.1.56 | 0.0091 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine | |
2.1.1.56 | 0.01 | - |
at pH 8.0 and 30°C | Homo sapiens | 3,4',5,7-tetrahydroxyflavone | |
2.1.1.56 | 0.011 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 1-(4-tert-butylphenyl)-N-methyl-N-[(naphthalen-1-yl)methyl]methanamine | |
2.1.1.56 | 0.0135 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine | |
2.1.1.56 | 0.0137 | - |
at pH 8.0 and 30°C | Homo sapiens | 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine | |
2.1.1.56 | 0.0143 | - |
at pH 8.0 and 30°C | Homo sapiens | 1-[bis(4-fluorophenyl)methyl]-4-[(2Z)-3-phenylprop-2-en-1-yl]piperazine | |
2.1.1.56 | 0.0168 | - |
at pH 8.0 and 30°C | Homo sapiens | 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine | |
2.1.1.56 | 0.0184 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | (2R,6S)-2,6-dimethyl-4-[2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine | |
2.1.1.56 | 0.0237 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 3,4',5,7-tetrahydroxyflavone | |
2.1.1.56 | 0.031 | - |
at pH 8.0 and 30°C | Severe acute respiratory syndrome-related coronavirus | 3,8-diamino-5-[3-[diethyl(methyl)azaniumyl]propyl]-6-phenylphenanthridin-5-ium | |
2.1.1.56 | 0.03652 | - |
at pH 8.0 and 30°C | Homo sapiens | 2-(2-[4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl]ethoxy)ethan-1-ol | |
2.1.1.56 | 0.1022 | - |
at pH 8.0 and 30°C | Homo sapiens | (2-[4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl]ethoxy)acetic acid | |
2.1.1.56 | 0.159 | - |
at pH 8.0 and 30°C | Homo sapiens | 1-(diphenylmethyl)-4-methylpiperazine hydrochloride (1:1) | |
2.1.1.56 | 0.2268 | - |
at pH 8.0 and 30°C | Homo sapiens | 1-[(4-chlorophenyl)(phenyl)methyl]-4-methylpiperazine |